Tutorials
Kronos Bio Inc logo

Kronos Bio Inc

$ 4.78 -0.5 (-9.47%) 10:08 PM EST
P/E:
At Loss
P/B:
0.86
Market Cap:
$ 271.36M
Enterprise V:
$ 64.81M
Volume:
288.78K
Avg Vol (2M):
410.18K
Volume:
288.78K
Market Cap $:
271.36M
PE Ratio:
At Loss
Avg Vol (2-Month):
410.18K
Enterprise Value $:
64.81M
PB Ratio:
0.86
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Kronos Bio Inc
NAICS : 541714 SIC : 2833
1300 So. El Camino Real, Suite 300, San Mateo, CA, USA, 94402
Description
Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine strategy by targeting dysregulated transcription.
Name Current Vs Industry Vs History
Cash-To-Debt 9.06
Equity-to-Asset 0.87
Debt-to-Equity 0.11
Debt-to-EBITDA -0.21
Interest Coverage N/A
N/A
N/A
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -127.9
3-Year EPS without NRI Growth Rate -104.7
3-Year FCF Growth Rate -103.7

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 41.11
9-Day RSI 47.61
14-Day RSI 50.8
6-1 Month Momentum % -41.1
12-1 Month Momentum % -77.83

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 18.19
Quick Ratio 18.19
Cash Ratio 17.75

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -25.1

Financials (Next Earnings Date:2022-11-09 Est.)

KRON's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:KRON

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -2.98
Beta 0
Volatility % 60.9
14-Day RSI 50.8
14-Day ATR ($) 0.403698
20-Day SMA ($) 4.95275
12-1 Month Momentum % -77.83
52-Week Range ($) 2.96 - 25.01
Shares Outstanding (Mil) 56.77

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Kronos Bio Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More